Partial Modified Blair Incision on Benign Tumor Parotidectomy Scar's Characteristics

Salivary Gland Tumor Clinical Trial

— MiniBlair  

Official title:

Effect of Parotid Mass Location on Benign Tumor Parotidectomy Scar's Characteristics

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04970875
• Other study ID #: NHR010619
• Status: Completed
• Start date: June 1, 2021
• Est. completion date: June 15, 2021

Study information

• Verified date: April 2023
• Source: Western Galilee Hospital-Nahariya
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Parotidectomy is the treatment of choice for tumors in the parotid gland, with the modified Blair is the most common incision used. In our medical center, the incision is tailored to the size and location of the specific parotid tumor. This retrospective analysis aims to determine the incidence of complications and to assess the relation between the mass and scar characteristics in patients who had undergone parotidectomy.

Description:

The scar characteristics of patient who had undergone parotidectomy for benign neoplasms at our medical center between 2013 and 2019 will be evaluated. Patients will complete a questionnaire regarding the occurrence of complications.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: June 15, 2021
• Est. primary completion date: June 15, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age above 18 years during the surgery

• Clinical diagnosis of a benign parotid pathology

Exclusion Criteria:

• A malignant pathology of the parotid gland

• Unavailable data

Related Conditions & MeSH terms

• Salivary Gland Neoplasms
• Salivary Gland Tumor

Intervention

Other:
• Questionnaire
QoL questionnaire

Locations

Country	Name	City	State
Israel	Galilee Medical Center	Nahariya

Sponsors (1)

Lead Sponsor	Collaborator
Western Galilee Hospital-Nahariya

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of Treatment-Emergent Adverse Events as assessed by a questionnaire.	The Warmald Parotidectomy Complications Questionnaire consists of five items, each addressing a complication common to parotidectomy: numbness of the ear on the operated side, Frey's syndrome, facial depression or deformity, noticeable scar, and pain or discomfort in the scar. Subjects are asked to indicate the extent to which they were disturbed by each of these complications on a scale ranging from 1 (never) to 10 (always).	1 Year